Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Virology

• Publication date

  2008-12-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2008.09.010PMID 18930512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses

  2007cited by this paper
• High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.

  2007cited by this paper
• Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.

  2007cited by this paper
• Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.

  2007cited by this paper
• Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses?

  2007cited by this paper
• Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

  2007cited by this paper
• N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization

  2006cited by this paper
• Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus

  2006cited by this paper
• Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness.

  2006cited by this paper
• Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations

  2006cited by this paper
• Inhibition of HIV entry by carbohydrate-binding proteins.

  2006cited by this paper
• Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry.

  2006cited by this paper
• Structure of a V3-Containing HIV-1 gp120 Core

  2005cited by this paper
• Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins

  2005cited by this paper
• Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

  2005cited by this paper
• Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

  2005cited by this paper
• A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.

  2005cited by this paper
• Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis

  2005cited by this paper
• Proteins that bind high-mannose sugars of the HIV envelope.

  2005cited by this paper
• The C108g Epitope in the V2 Domain of gp120 Functions as a Potent Neutralization Target When Introduced into Envelope Proteins Derived from Human Immunodeficiency Virus Type 1 Primary Isolates

  2005cited by this paper
• Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins

  2004cited by this paper
• Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

  2004cited by this paper
• Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3

  2004cited by this paper
• Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

  2004cited by this paper
• Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition

  2003cited by this paper
• Role of N-Linked Glycans in a Human Immunodeficiency Virus Envelope Glycoprotein: Effects on Protein Function and the Neutralizing Antibody Response

  2002cited by this paper
• The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

  2002cited by this paper
• env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors

  2002cited by this paper
• The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization.

  2002cited by this paper
• Loss of a Single N-Linked Glycan Allows CD4-Independent Human Immunodeficiency Virus Type 1 Infection by Altering the Position of the gp120 V1/V2 Variable Loops

  2001cited by this paper
• N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism

  2001cited by this paper
• Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.

  2001cited by this paper
• V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies

  2000cited by this paper
• Identification of Replication-Competent Strains of Simian Immunodeficiency Virus Lacking Multiple Attachment Sites for N-Linked Carbohydrates in Variable Regions 1 and 2 of the Surface Envelope Protein

  1998cited by this paper
• Effect of Major Deletions in the V1 and V2 Loops of a Macrophage-Tropic HIV Type 1 Isolate on Viral Envelope Structure, Cell Entry, and Replication

  1998cited by this paper
• The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.

  1998cited by this paper
• The antigenic structure of the HIV gp120 envelope glycoprotein

  1998cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein

  1997cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain

  1995cited by this paper
• A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody

  1994cited by this paper
• Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions

  1993cited by this paper
• Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody

  1993cited by this paper
• Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding

  1993cited by this paper
• Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.

  1992cited by this paper
• Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

  1991cited by this paper
• Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

  1990cited by this paper
• HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

  1990cited by this paper
• Related mannose‐specific lectins from different species of the family Amaryllidaceae

  1988cited by this paper
• The Urtica dioica Agglutinin Is a Complex Mixture of Isolectins.

  1988cited by this paper
• Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.

  1988cited by this paper
• Van Damme A.

  1986cited by this paper

• Modification of N-glycosylation site in the spike protein enhances the neutralizing antibody response against PEDV.

  2026cites this paper
• Post-translational modifications in drug resistance.

  2024cites this paper
• Glycosylation of viral proteins: Implication in virus–host interaction and virulence

  2022cites this paper
• HIV-1 Entry and Prospects for Protecting against Infection

  2021cites this paper
• Lectin in Host Defense Against Microbial Infections

  2020cites this paper
• Siglecs at the Host–Pathogen Interface

  2020cites this paper
• Harnessing post-translational modifications for next-generation HIV immunogens.

  2018cites this paper
• Molecular Characteristics of the Envelope of Vertically Transmitted HIV-1 Strains from Infants with HIV Infection

  2017cites this paper
• Characterization of Envelope Surface Glycoprotein from HIV-2 Primary Isolates with Different Coreceptor Usage Profile

  2017cites this paper
• Arenaviruses: mechanisms of antibody-mediated neutralization and an alternative route of entry

  2017cites this paper
• Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission

  2015cites this paper
• Sensitivity of transmitted and founder human immunodeficiency virus type 1 envelopes to carbohydrate-binding agents griffithsin, cyanovirin-N and Galanthus nivalis agglutinin.

  2015cites this paper
• HIV-1 Envelope Glycan Moieties Modulate HIV-1 Transmission

  2014cites this paper
• Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity

  2014cites this paper
• Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication de fi cits

  2014cites this paper
• HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview

  2014cites this paper
• Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms

  2014cites this paper
• HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage

  2014cites this paper
• Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness.

  2014cites this paper
• The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents

  2014cites this paper
• Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits.

  2014cites this paper
• LCMV Glycosylation Modulates Viral Fitness and Cell Tropism

  2013cites this paper
• Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.

  2013cites this paper
• Glycosylation in HIV-1 envelope glycoprotein and its biological implications

  2013cites this paper
• In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor

  2012cites this paper
• Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins

  2012cites this paper
• The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry*

  2011cites this paper
• Profile of systemic treatment with the antiviral lectin Griffithsin in guinea pigs.

  2011cites this paper
• Carbohydrate Binding Agents: Potential Therapeutics with Multiple Inhibitory Actions against Enveloped Viruses

  2011cites this paper
• Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections

  2011cites this paper
• Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic,

  2010cites this paper
• Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use

  2010cites this paper
• Involvement of Envelope-Glycoprotein Glycans in HIV-1 Biology and Infection

  2010cites this paper
• Potential of carbohydrate‐binding agents as therapeutics against enveloped viruses

  2010cites this paper
• The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide.

  2010cites this paper